William Rosellini

will

William Rosellini is the President of CytoImmune Therapeutics, Inc, a clinical stage biotechnology company. Also, a serial life science entrepreneur, breaking down what worked and what didn't.

Reg D Basics

“Regulation D” (or Reg D) is a United States Federal program created under the Securities Act of 1933, indoctrinated in 1982, that allows companies the ability to raise capital through the sale of equity or debt securities (private or public stock shares). Specifically, this allows small businesses to raise capital from private investors, without going

Reg D Basics Read More »